key: cord-1002908-9gkhkyyj
authors: Villamizar-Peña, Rhuvi; Gutiérrez-Ocampo, Estefanía; Rodríguez-Morales., Alfonso J.
title: Pooled Prevalence of Diarrhea among COVID-19 Patients
date: 2020-05-16
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2020.05.014
sha: 10968fc70240f3539dc5a8fbdb2a16f2d691943f
doc_id: 1002908
cord_uid: 9gkhkyyj

nan

Rhuvi Villamizar-Peña, 1,a Estefanía Gutiérrez-Ocampo, 1 20.0%) in the random-effects model, and 2.3% (95%CI 1.3-3.3%) in the fixed-effects model ( Figure 1 ). In the case of MERS-CoV, this was 23.1% (95%CI 10.7-35.4%) and

17.5% (95%CI 13.1-21.9%), respectively ( Figure 1 ).

In addition to the cohort, cross-sectional, and case series studies, D'Amico et al., 1 also involved three case reports. We also looked at that and found six more case reports.

Most of them are from China (5), followed by Japan (2), USA (1), and Lebanon (1), with a median diarrhea duration of 3 days, and regarding the number of evacuations, those ranging from 2 to 6 per day. [2] [3] [4] [5] [6] [7] In a previous meta-analysis, we found that diarrhea was reported among 6.1% (95%CI 2.4-9.7%) patients with COVID-19 (6 studies, 457 patients), 8 which is the same prevalence obtained now with 31 studies and 3,335 patients by the fixed-effects model in the current analysis ( Figure 1 ). Although this would be considered a low prevalence, the COVID-19 pandemic has affected 3.8 million people worldwide (May 8, 2020), translating into between 210,051 and 268,399 diarrhea associated cases (based on 95% CI for pooled prevalence).

Because the SARS-CoV-2 may directly or indirectly affect the enteric mucosa, 1 diarrhea and other gastrointestinal findings should raise clinical suspicion for COVID-19, with or without presence of fever, cough and other respiratory and non-respiratory manifestations. 8 Finally, as D'Amico et al., 1 mentioned, fecal-oral spread transmission may be an additional source of transmission that deserves more research and subsequent preventive interventions.

The authors disclose no conflicts.

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management

CT Manifestations of Novel Coronavirus Pneumonia: A Case Report

A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs

Clinical features of pediatric patients with COVID-19: a report of two family cluster cases

Atypical presentation of SARS-CoV-2 infection: A case report

A case of COVID-19 patient with the diarrhea as initial symptom and literature review

First Case of an Infant with COVID-19 in the Middle East

2020:101623. Epub 2020/03/18. Figure 1. Random-and fixed-effects model for the pooled prevalence of diarrhea among COVID-19 patients. Additional studies included after

A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019

The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients

Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

Clinical characteristics of 19 neonates born to mothers with COVID-19

Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau

Novel coronavirus infection in children outside of Wuhan, China. Pediatr Pulmonol

Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

A major outbreak of severe acute respiratory syndrome in Hong Kong

CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city